Ann: Appendix 4E & Full Year Statutory Accounts, page-4

Amazing report.

• PAA has liquidated its only operating subsidiary, has no operations, does not generate cash (some interest) and does not have enough cash for the next 12 months yet there is no emphasis of matter from the auditors re going concern. They must know something we dont.
• the standard directors report wording is a sham for PAA. Remuneration is not performance based
• Sam the Sham the the Bassett hound both have their snouts in PAA's money trough
• No talk of commercialisation. Give us a break...its either a CR or commercial deal but deafening silence
• Nothing on the doggie trial being finalized this quarter
• No indication of timelines when the MND results are likely to be known/released
• No indication of funding/timelines for Phase 2 MND or human cancer trials.
• No time line for application for Orphan Drug Designation

Some nice preliminary information on the trials to date but mMore of the same wishy washy wording when it comes to future plans, timelines and funding. No wonder on investors are interested.

Can only hope the new CEO runs the riot act over the directors and Roger the dodger fades into the setting sun